EUCTR2011-006151-10-DK
Active, not recruiting
Not Applicable
FAME - Fampyra outcome measures study: a study of responsiveness of different outcome measures to Fampyra treatment. - FAME
Sønderjylland Hospital, department of neurology0 sitesFebruary 15, 2012
DrugsFampyra
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Multiple Sclerosis
- Sponsor
- Sønderjylland Hospital, department of neurology
- Status
- Active, not recruiting
- Last Updated
- 12 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with clinically definite multiple sclerosis diagnosed according to the McDonald criteria, aged 18\-60 years, EDSS 4\-7, pyramidal FS \>\= 2, able to transport self to University of Southern Denmark in Odense.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) no
- •F.1\.2\.1 Number of subjects for this age range 125
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •History of epileptic seizures, relapses of multiple sclerosis or change in disease modifying therapy within 60 days, cancer within five years, uncontrolled hypertension or clinically important cardiac, hepatic, renal or pulmonary disease, pregnancy and concomitant tratment with cimetidine, carvedilol, propranolol or metformine.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Improvement of quality of life of wives of alcoholics through family supportCTRI/2020/04/024568Mrs Shiji PJ
Completed
Phase 2
Effectiveness of Family-Based Interventions on Family Members of Bipolar PatientsBipolar Disorder.Bipolar affective disorderIRCT2017061434533N1Vice Chancellor for Research of Social Welfare and Rehabilitation Sciences University.60
Not yet recruiting
Not Applicable
An Observational study to assess the effect of fastfood available on streets on the status of Rasa dhatu(CVS)in youths(College going students).CTRI/2022/04/041675Vasundhara Ramesh Mahewar
Active, not recruiting
Phase 1
A study evaluating the safety and efficacy of 19CP02 in subjects with non-Hodgkin lymphomaRelapsed/refractory B-cell non-Hodgkin lymphomaMedDRA version: 20.0Level: HLGTClassification code 10025320Term: Lymphomas non-Hodgkin's B-cellSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2021-003272-13-NLCellPoint B.V.45
Active, not recruiting
Phase 1
A study evaluating the safety and efficacy of 19CP02 in subjects with non-Hodgkin lymphomaEUCTR2021-003272-13-BECellPoint B.V.45